• KOL
    • KOLs Community
    • Bacillary
    • Bacillary Angiomatosis
    • Timothy G Berger
    • Timothy G Berger

      Timothy G Berger

      Department of Dermatology, University of California, San Francisco, California, USA | 3University of California at San Francisco, San Francisco, CA, USA | Department of ...

       

       

      KOL Resume for Timothy G Berger

      Year
      2021

      Department of Dermatology, University of California, San Francisco, California, USA

      2020

      Department of Dermatology, University of California, San Francisco

      2019

      Department of Dermatology, University of California, San Francisco, San Francisco, CA, United States.

      2017

      Department of Dermatology, University of California San Francisco, San Francisco, CA, USA

      2016

      Department of Dermatology, University of California, San Francisco, School of Medicine, San Francisco, California

      2015

      School of Medicine University of California Department of Dermatology San Francisco CA USA

      Department of Dermatology, University of California San Francisco

      2014

      Department of Dermatology, University of California San Francisco, San Francisco, California

      2013

      Department of Dermatology, University of California, San Francisco, San Francisco, CA, United States

      2012

      Department of Dermatology, University of California–San Francisco, San Francisco, California

      2011

      Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA.

      2010

      Department of Dermatology at the University of California, San Francisco, San Francisco, California

      2009

      Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA

      2008

      Department of Dermatology, University of California, San Francisco, San Francisco, California.

      2006

      Department of Dermatology, University of California, San Francisco, California, USA.

      2005

      Departments of Dermatology

      University of California, San Francisco and

      2004

      From the Department of Dermatology, University of California, San Francisco

      2002

      Department of Dermatology, University of California, San Francisco, California, USA, US

      2001

      From the WIHS Collaborative Study Group; University of California, San Franciscoa; University of Southern California, Los Angelesb; Mt Sinai Medical Center, New Yorkc; Cook County Hospital, Chicagod; Georgetown University Medical Center, Washingtone; State University of New York Health Science Center at Brooklynf; and Johns Hopkins School of Hygiene and Public Health, Baltimore.g

      San Francisco and Los Angeles, California; New York and Brooklyn, New York; Chicago, Illinois; Washington, DC; and Baltimore, Maryland

      2000

      the Department of Dermatology, San Francisco General Hospital, San Francisco, California, USA

      University of California Department of Dermatology San Francisco U.S.A.

      1999

      San Francisco, California

      1998

      Departments of Dermatology, University of California, San Francisco, CA, USA

      1997

      From the Departments of Medicine (J.E.K., C.S.G.), Dermatology (M.J.W., T.G.B., P.E.L., J.W.T.), and Pathology (P.E.L.), University of California, San Francisco

      1996

      University of California, San Francisco, 400 Parnassus, Box 0316, 94143, San Francisco, CA

      the Dermatology Service, San Francisco General Hospital, San Francisco, California, USA

      1995

      Department of Dermatology, San Francisco General Hospital, San Francisco, California, USA.

      1994

      Department of Dermatology, University of California, San Francisco.

      San Francisco, California, USA

      1993

      Department of Dermatology, University of California School of Medicine, San Francisco, CA, USA

      1992

      Dermatology Service, Department of Medicine, Letterman Army Medical Center, Presidio, San Francisco, California USA

      1991

      Chief, Department of Dermatology, San Francisco General Hospital; and Assistant Clinical Professor of Dermatology, University of California, San Francisco, San Francisco, California

      1989

      Departments of Pathology (P.E.L., B.M.E., J.H.B., T.S.B.Y.), Dermatology (P.E.L., T.G.B., B.M.E.), and Laboratory Medicine (J.H.B.), School of Medicine, University of California, San Francisco, California; the Section of Dermatology, San Francisco General Hospital (T.G.B.); and the Department of Pathology and Laboratory Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, New York (M.H.S.).

      Department of Dermatology, San Francisco General Hospital, CA.

      San Francisco General Hospital San Francisco, CA 94110, USA

      1988

      From the Dermatology Service, Department of Medicine, Letterman Army Medical Center, Presidio of San Francisco

      1987

      From the Dermatology Service Department of Medicine, Letterman Army Medical Center, Presidlo of San Francisco, CA

      San Francisco, USA

      Dermatology Service, Department of Medicine, Letterman Army Medical Center, U.S.A.

      1986

      Dermatology Service, Department of Medicine, Letterman Army Medical Center, Presidio of San Francisco, California

      1985

      the Dermatology Service, Letterman Anny Medical Center, Presidio of San Francisco, CA

      1984

      Armed Forces Institute of Pathology and the Veterans Administration Special Reference Laboratory for Pathology, Washington, DC

      San Francisco, CA, USA

       

       

      Timothy G Berger: Influence Statistics

      Sample of concepts for which Timothy G Berger is among the top experts in the world.
      Concept World rank
      keloidalis nuchae keloidalis #1
      lesions kaposi #1
      reported cases mtx #1
      healthcare behaviors elements #1
      entities bullosa #1
      13 hivseropositive patients #1
      undiversion patient #1
      helper tcell count #1
      patients lichenoid eruptions #1
      ederm clerkship #1
      dermatology clinics university #1
      dermatology clerkship #1
      clinical photodermatitis #1
      center dermatology clinics #1
      hivinfected patients mtx #1
      rediversion entities #1
      prp rubra pilaris #1
      lichenoid photoeruptions #1
      uvb 13 patients #1
      psoralen uva exhibit #1
      12 acquired #1
      dideoxyinosine sulfamethoxazole #1
      pruritus elderly patients #1
      photodermatitis native ancestry #1
      eventual pigmentation #1
      medications dideoxyinosine #1
      thalidomide 100 subjects #1
      subsequent immune restoration #1
      neurological interactions #1
      pruritus evidence review #1
      hyperpigmentation inbred c57bl #1
      ederm #1
      dermatologists diagnose #1
      tpn neuropathy #1
      hivassociated pruritus #1
      hiv diseases treatment #1
      aad online curriculum #1
      diagnosis ederm #1
      students perceptions usability #1
      selective hyperpigmentation #1
      background bacillary #1
      reported cases polychondritis #1

       

      Prominent publications by Timothy G Berger

      KOL-Index: 18485

      An association between erythema multiforme and herpes simplex virus infection has been supported by clinical studies and by the detection by immunofluorescence of herpes viral antigen in sera and skin biopsy specimens of patients with erythema multiforme. In rare cases, the virus has also been isolated in cultures of skin biopsy specimens of erythema multiforme. To investigate further the association between erythema multiforme and herpes simplex virus, we used the polymerase chain ...

      Known for Simplex Virus | Erythema Multiforme | Polymerase Chain Reaction | Viral Dna | Skin Lesions
      KOL-Index: 9769

      The appropriate use criteria process synthesizes evidence-based medicine, clinical practice experience, and expert judgment. The American Academy of Dermatology in collaboration with the American College of Mohs Surgery, the American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery has developed appropriate use criteria for 270 scenarios for which Mohs micrographic surgery (MMS) is frequently considered based on tumor and patient characteristics. ...

      Known for Mohs Surgery | Situ Carcinoma | Dermatology College | Basal Cell | Evidencebased Medicine
      KOL-Index: 9765

      BACKGROUND: Bacillary angiomatosis and bacillary peliosis are vascular proliferative manifestations of infection with species of the genus bartonella that occur predominantly in patients infected with the human immunodeficiency virus. Two species, B. henselae and B. quintana, have been associated with bacillary angiomatosis, but culture and speciation are difficult, and there has been little systematic evaluation of the species-specific disease characteristics. We studied 49 patients ...

      Known for Molecular Epidemiology | Bartonella Infections | Henselae Quintana | Patients Bacillary Angiomatosis | Bacillary Peliosis
      KOL-Index: 9021

      BACKGROUND: Bacillary angiomatosis is characterized by vascular lesions, which occur usually in patients infected with the human immunodeficiency virus (HIV). A newly described gram-negative organism, Rochalimaea henselae, has been associated with cutaneous bacillary angiomatosis, but no organism has been isolated and cultivated directly from cutaneous tissue.

      METHODS: We used two methods to isolate the infecting bacterium from four HIV-infected patients with cutaneous lesions suggestive ...

      Known for Bacillary Angiomatosis | Rochalimaea Species | Patients Quintana | Cutaneous Lesions | Blood Patient
      KOL-Index: 8931

      IntroductionIntense nocturnal pruritus as well as the complex pathophysiology of atopic dermatitis (AD) can severely affect sleep and become a major factor in negatively impacting quality of life in adults. However, much of the literature on sleep disturbance in AD patients is on the pediatric population, and it is not well studied in adults. Furthermore, limited studies are available to guide effective management of sleep disturbance in AD in general. We review the literature to present ...

      Known for Sleep Disturbance | Adults Atopic Dermatitis | Major Factor | Effective Management | Disease Control
      KOL-Index: 7746

      Objective: To examine risk factors for the development of cutaneous squamous cell carcinoma (SCC) in a group of human immunodeficiency virus (HIV)— infected patients, including evaluation and detection of epidemiologic risk factors of human papillomavirus (HPV) and p53 expression.Design: Case-control study during a 3-year period.Setting: Dermatologic referral center.Patients: Thirty-three HIV-infected patients who had 97 SCCs were compared with 24 HIV-infected patients who had 70 basal ...

      Known for Human Papillomavirus | Cell Carcinoma | Hivinfected Patients | Immunodeficiency Virus | Cutaneous Squamous
      KOL-Index: 7586

      Background and Design: This study determines (1) the readiness of primary care physicians (PCPs) to triage optimally lesions suspicious for skin cancer, (2) the difference in their abilities from those of dermatologists, and (3) whether accurate diagnosis after viewing slide images transfers to accurate diagnosis after viewing lesions on patients. Seventy-one primary care residents and 15 dermatologists and resident dermatologists diagnosed and selected a treatment/diagnostic plan for ...

      Known for Skin Cancer | Primary Residents | Accurate Diagnosis | Malignant Melanomas | Lesions Dermatologists
      KOL-Index: 7484

      OBJECTIVE: To evaluate safety and efficacy of thalidomide in the treatment of prurigo nodularis in a group of human immunodeficiency virus (HIV)-infected patients whose condition was recalcitrant to standard treatment.

      DESIGN: Prospective study.

      SETTING: Outpatient dermatology and neurology clinic, both referral settings.

      PATIENTS: Eight HIV-infected patients with refractory prurigo nodularis; a total of 10 met inclusion criteria, but 2 could not be followed up.

      INTERVENTIONS: Treatment ...

      Known for Prurigo Nodularis | Thalidomide Treatment | Human Immunodeficiency Virus | Peripheral Neuropathy | Immunosuppressive Agents
      KOL-Index: 7360

      Certain skin cancers occur with increased frequency or altered course in patients infected with HIV. Malignant melanoma and squamous cell carcinoma are examples of cutaneous malignancies that have a more aggressive course in patients with HIV. Others, such as basal cell carcinoma, appear more frequently in this population but do not appear to be more aggressive. The incidence of HIV-associated Kapsosi's sarcoma has markedly decreased since the advent of HIV antiretroviral therapy. Our ...

      Known for Cutaneous Malignancy | Anaplastic Lymphoma | Basal Cell Carcinoma | Patients Hiv | Skin Cancers
      KOL-Index: 7269

      The acquired immunodeficiency syndrome (AIDS) epidemic has had a profound impact on our understanding of Kaposi's sarcoma (KS). Epidemiologic features suggest a sexually transmitted cofactor in the pathogenesis of AIDS-associated KS (AIDS-KS), and several putative agents have received intense scrutiny. Cell culture studies suggest that the angiogenesis of AIDS-KS is stimulated by both human immunodeficiency virus proteins and growth factors that may be involved in the development and ...

      Known for Clinical Spectrum | Ks Patients | Local Therapy | Sarcoma Kaposi | Cutaneous Lesions

      Key People For Bacillary Angiomatosis

      Top KOLs in the world
      #1
      Jane E Koehler
      bacillary angiomatosis bartonella henselae domestic cats
      #2
      Philip E LeBoit
      mycosis fungoides bacillary angiomatosis situ hybridization
      #3
      Timothy G Berger
      bacillary angiomatosis atopic dermatitis human immunodeficiency virus
      #4
      Jordan W Tappero
      antiretroviral therapy bacillary angiomatosis hiv infection
      #5
      Mark H Stoler
      human papillomavirus situ hybridization cervical cancer
      #6
      Roy T Steigbigel
      lymph nodes human immunodeficiency virus albumin synthesis

      Timothy G Berger:Expert Impact

      Concepts for whichTimothy G Bergerhas direct influence:Bacillary angiomatosis,  Atopic dermatitis,  Human immunodeficiency virus,  Human papillomavirus,  Hiv infection,  Skin cancer,  Herpes simplex virus,  Patients aids.

      Timothy G Berger:KOL impact

      Concepts related to the work of other authors for whichfor which Timothy G Berger has influence:Atopic dermatitis,  Bacillary angiomatosis,  Hiv infection,  Bartonella henselae,  Skin cancer,  Kaposi sarcoma,  Scratch disease.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Department of Dermatology, University of California, San Francisco, California, USA | 3University of California at San Francisco, San Francisco, CA, USA | Department of Dermatology, University of California, San Francisco | Department of Dermatology,

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.